Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
Clinical trial NCT06654193 · RECRUITING
Trial details
- NCT number
- NCT06654193
- Sponsor
- Hope Biosciences LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.